Stockreport

Agenus Expands Medical Affairs Infrastructure to Support Increasing Physician Requests for Authorized Access to Botensilimab Plus Balstilimab

Agenus Inc.  (AGEN) 
Last agenus inc. earnings: 3/12 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: agenusbio.com/investors
PDF Medical Affairs scale-up supports France’s multi-tumor AAC access framework and expanding paid named-patient programs requests LEXINGTON, Mass.--(BUSINESS WIRE)--Agen [Read more]